CytImmune Sciences is a clinical stage nanomedicine company which discovers, develops and commercializes multifunctional, tumor-targeted cancer therapies. The company was founded in 1988 and headquartered in Rockville, United States. It has raised $15M in early stage funding, with backing from Maryland Venture Fund, Montgomery County Government, Maryland, NIH. The company operates in the High Tech - Nanotechnology, Life Sciences - Immunotherapy, Life Sciences - Oncology space. Multifunctional and tumor-targeted cancer therapies. Its offerings span Oncology - Drugs - Diversified. The company's offerings encompass Nanotechnology - Nanoenabled Products - Life Science - Drugs - Cancer, Oncology - Drugs - Diversified. Within the High Tech - Nanotechnology and Life Sciences - Immunotherapy and Life Sciences - Oncology landscape, the company aims to address evolving market needs through its specialized approach.
← All startups
Cytimmune
Early StageCytImmune Sciences is a clinical stage nanomedicine company which discovers, develops and commercializes multifunctional, tumor-targeted cancer therapies. The company was founded in 1988 and headquartered in Rockville, United States. It has raised $15M in early stage funding, with backing from Maryland Venture Fund, Montgomery County Government, Maryland, NIH. The company operates in the High Tech - Nanotechnology,…
About
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drugs > Cancer,
Oncology > Drugs > Diversified
Institutional investors
Maryland Venture FundMontgomery County GovernmentMarylandNIH
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.